venous thromboembolism
Conditions
Interventions
Gold Standard:2018 Version of the "Guidelines for the Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism": Imaging Examination Criteria for the Diagnosis of Venous Thromboembolism
Index test:1. Dynamic monitoring of coagulation and platelet function
2. Thromboelastography
3. Six coagulation tests
4. Blood routine examination
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1.Observation group: 1) age >= 18 years; 2) hospital stay > 48 hours; 3) VTE diagnosed 48 hours after admission (in accordance with the 2018 version of the "Guidelines for the Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism" VTE diagnosis-related imaging examination standards): PTE diagnosis examinations include computed tomography pulmonary angiography, radionuclide pulmonary ventilation/perfusion imaging, magnetic resonance pulmonary angiography, pulmonary angiography, etc. DVT diagnosis imaging examinations include pressurized venous ultrasound, computed tomography venography, radionuclide venous imaging, venography, etc. 4) Medical records, clinical data, blood routine and other laboratory examination data are complete. 2.Control group: 1) Age = 18 years old; 2) Hospitalization time > 48 hours; 3) No VTE was diagnosed during hospitalization; 4) Complete medical records, clinical data, blood routine and other laboratory tests.
Exclusion criteria
Exclusion criteria: 1) Age <18 years, hospitalization time <48 hours; 2) Patients diagnosed with VTE within 48 hours of admission; 3) patients diagnosed with VTE 48 hours after admission but with significant VTE symptoms and signs at admission; 4) Those who have not undergone routine blood tests, six coagulation tests, coagulation and platelet function analysis, thromboelastography and other tests, or whose clinical data are incomplete; 5) Patients with chronic VTE, arterial thrombosis, and deep vein thrombosis other than lower extremities; 6) Pregnant or postpartum women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The dynamic monitoring indicators for coagulation and platelet function;Thromboelastography;Accuracy;Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Six coagulation tests;Blood routine examination;Positive predicative value;Negative predictive value; | — |
Countries
China
Contacts
Public ContactYing Cui
The First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed